News | July 13, 2011

Akron Children's Hospital to Demonstrate Heart Ablation Procedure via Live Webcast

July 13, 2011 – Many children and teens suffering from tachycardia, or rapid heart rate, have relied on medication to regulate their heart rhythms and control symptoms such as fatigue, dizziness and fainting spells. However, doctors at the Akron Children's Hospital Arrhythmia Center have made great strides in curing tachycardia with minimally invasive procedures.

Their skills will be on display during a one-hour webcast that will be available beginning Thursday, July 14, at 6 p.m. (Eastern). The webcast will include footage from a cryoablation procedure, as well as interviews with Arrhythmia Center director John Clark, M.D., associate director Grace Smith, M.D., and the patient and family.

During the cryoablation procedure, electrode catheters – long, slender, flexible wires – are threaded into the heart to map or locate the precise area of the heart causing the irregular rhythm. Once identified, the surgeon destroys the abnormal heart tissue by freezing it off with nitrous oxide. In other cases, radiofrequency ablation is used to burn the affected area.

Clark and Smith recommend cryoablations as the primary therapy for children age 5 and older with rapid heart rates. Approved by the U.S. Food and Drugs Administration (FDA) in 2003, Akron Children's was the first pediatric hospital in Ohio to offer cryoablation, which cures 90 to 95 percent of patients.

Clark and Smith perform most cardiac ablations without radiation, an advancement significant to young patients at risk of lifelong cumulative radiation exposure through regular diagnostic procedures.

For more information: www.akronchildrens.org


Related Content

News

Feb. 6, 2026 — Abbott has announced new clinical data from two late-breaking presentations at AF Symposium in Boston ...

Home February 06, 2026
Home
News

Jan. 20, 2026 — Abbott has received CE Mark in Europe for the TactiFlex Duo Ablation Catheter, Sensor Enabled to treat ...

Home January 22, 2026
Home
News

Jan. 20, 2026 — Kardium Inc. has announced the publication of the PULSAR clinical trial results in the Journal of the ...

Home January 21, 2026
Home
Feature | Kyle Hardner

Robotic Magnetic Navigation (RMN) emerged two decades ago as an alternative approach to performing complex ablation ...

Home January 09, 2026
Home
News

Jan. 6, 2026 — Stereotaxis, a supplier of surgical robotics for minimally invasive endovascular intervention, has ...

Home January 06, 2026
Home
News

Oct. 10, 2025 — Johnson & Johnson MedTech, in collaboration with the Heart Rhythm Clinical and Research Solutions, LLC ...

Home October 13, 2025
Home
News

Sept. 2, 2025 — Johnson & Johnson MedTech has announced acute safety and effectiveness results from the Varipure ...

Home September 05, 2025
Home
News

Sept. 3, 2025 — Kardium Inc. recently announced it has received pre-market approval (PMA) for the Globe Pulsed Field ...

Home September 03, 2025
Home
News

July 14, 2025  –  Johnson & Johnson MedTech has announced U.S. Food and Drug Administration (FDA) approval of an update ...

Home July 14, 2025
Home
News

July 7, 2025 — Catheter ablation is a minimally invasive treatment for abnormal heart rhythms. It is often successful in ...

Home July 09, 2025
Home
Subscribe Now